Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

SEL ICB Lambeth Community Denosumab Service

NHS South East London Integrated Care Board

This public procurement record has 6 releases in its history.

TenderUpdate

29 Jul 2026 at 14:05

Tender Notice
TenderUpdate

08 Jul 2026 at 09:13

Tender Notice
TenderUpdate

07 Jul 2026 at 12:46

Tender Notice
TenderUpdate

28 Apr 2026 at 12:48

Tender Notice
TenderUpdate

28 Apr 2026 at 12:15

Tender Notice
Award

28 Apr 2026 at 11:40

Award Notice
Summary of the contracting process

NHS South East London Integrated Care Board procured the Lambeth Community Denosumab Service, a community-based shared-care healthcare service for administering and monitoring denosumab 60mg/ml for osteoporosis. The service covers patients identified by secondary care as clinically suitable for community treatment who are Lambeth residents or registered with a Lambeth GP. The provider is responsible for blood monitoring, prescribing support and timely denosumab injections, while clinical responsibility remains with secondary care. Delivery takes place in community healthcare settings in Lambeth, within the South East London osteoporosis pathway and shared-care arrangements. The procurement falls within medical personnel services (CPV 85141000) and is intended to support care closer to home and a better patient experience.

The contract was formally awarded to Lambeth Healthcare Ltd on 19 May 2026 under the Provider Selection Regime’s Direct Award Process C, without competition. The contract value is £49,140 excluding VAT. The initial contract period runs from 1 June 2026 to 30 November 2026, with an option for one further six-month extension, potentially continuing to 31 May 2027. The award followed a standstill period ending at 23:59 on 12 May 2026, during which providers could submit representations. The existing provider was selected because it was meeting the service, clinical, quality and performance requirements, with continuity of care considered essential. No competitive award criteria were applied.

This requirement is relevant to established healthcare providers able to deliver community-based osteoporosis shared care, rather than general medical staffing suppliers. A credible provider would need clinical capability in denosumab administration, blood monitoring and prescribing support, with robust arrangements for referrals from secondary care and treatment at appropriate intervals. It would also need to work within the South East London Shared Care Agreement and osteoporosis pathway, follow NICE TA204, and serve Lambeth residents or patients registered with Lambeth GP practices. The selected supplier demonstrated sustained high-quality performance, timely patient contact within 72 hours, patient information and reminder processes, incident reporting, service-user feedback, sound financial management and consistently strong patient satisfaction.

How relevant is this notice?

Notice Information

Notice Title

SEL ICB Lambeth Community Denosumab Service

Notice Description

Provision of a community-based shared care service for the administration and monitoring of denosumab 60mg/ml for osteoporosis. The service will support patients in Lambeth (or registered with a Lambeth GP) who have been identified by secondary care as clinically appropriate for treatment in the community. The Provider will deliver blood monitoring, prescribing support, and timely administration of injections in accordance with the South East London Shared Care Agreement, while clinical responsibility remains with secondary care.

Lot Information

Lot 1

This notice relates to the Lambeth Community Denosumab Service and is an intention to award a contract to the existing provider via Direct Award Process C. The service provides a community-based shared care pathway for patients prescribed denosumab 60mg/ml for the treatment of osteoporosis. Patients remain under the clinical responsibility of secondary care within South East London, in accordance with the South East London Shared Care Agreement for Denosumab. Secondary care will identify and refer a cohort of clinically appropriate patients for management in the community setting. The Provider will be responsible for delivering the community service, including required blood monitoring, prescribing support, and administration of denosumab injections at clinically appropriate intervals. The service is available to patients referred by secondary care who are registered with a GP in Lambeth or are Lambeth residents and who meet the eligibility criteria set out in the contract and Shared Care Agreement. The estimated contract value is PS49,140 per annum. The contract duration is 6 months from 01/06/2026 to 30/11/2026, with an option to extend for a further 6 months at the discretion of the Authority, up to 31/05/2027. This is a direct award with no competition under the Provider Selection Regime (PSR) - Direct Award Process C. As such, no award criteria were applied. The contracting authority has determined that the existing provider will be awarded the contract on the basis that: The current provider is delivering the service to a satisfactory standard. There are no proposed changes to the existing contract terms. Continuity of care is essential for this patient cohort The provider continues to meet all relevant clinical, quality, and service requirements. The decision is made in accordance with PSR requirements for Direct Award Process C. Additional information: Procurement Route This contract is intended to be awarded under the Provider Selection Regime (PSR) - Direct Award Process C. Rationale for Direct Award The current provider is delivering the service to a satisfactory standard, and there are no proposed changes to the existing contract terms. Continuity of care is essential for this patient cohort. The provider continues to meet all relevant clinical, quality, and service requirements. Decision The Contracting Authority intends to award the contract to the existing provider in accordance with PSR Direct Award Process C.

Options: The Contracting Authority may, at its discretion, may extend the contract for a further period of up to 6 months.

Procurement Information

Justification: Award of a contract without prior publication of a call for competition in the cases listed below Reason: The procurement falls outside the scope of application of the regulations Explanation: This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to the relevant authority by Tuesday 12th May 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-068c80
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/071732-2026
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Limited
Procurement Method Details
Award procedure without prior publication of a call for competition
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

85 - Health and social work services

CPV Codes

85141000 - Services provided by medical personnel

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
£49,140 Under £100K

Notice Dates

Publication Date
29 Jul 20264 weeks ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
22 Apr 20264 months ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS South East London Integrated Care Board
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDON
Postcode
SE1 2TZ
Postcode Area
South East London
Country
England
Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI4 Inner London - East
Small Region (ITL 3)
TLI44 Lewisham and Southwark
Delivery Location
TLI45 Lambeth
Local Authority
Southwark
Electoral Ward
London Bridge & West Bermondsey
Westminster Constituency
Bermondsey and Old Southwark

Supplier Information

Number of Suppliers
1
Supplier Name

Lambeth Healthcare Ltd

Further Information

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...